Inotiv (NOTVQ) Total Non-Current Liabilities (2014 - 2026)
Inotiv's (NOTVQ) quarterly Total Non-Current Liabilities came in at $595.8 million in Q1 2026, up 4.35% YoY from $570.9 million in Q1 2025, and little changed on a QoQ basis from $597.2 million in Q4 2025.
Inotiv (NOTVQ) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Inotiv (NOTVQ) has 10 years of Total Non-Current Liabilities data on file, last reported at $595.8 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 4.35% year-over-year to $595.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $595.8 million (up 4.35% YoY) and the FY2025 annual result came in at $606.7 million, up 5.35% from the prior year.
- Total Non-Current Liabilities held at $595.8 million in Q1 2026, from $597.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $606.7 million in Q3 2025 to a low of $520.1 million in Q1 2022.
- A 5-year average of $576.1 million and a median of $575.9 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 175.95% — and 2023, when it slipped 3.73%.
- Tracing NOTVQ's Total Non-Current Liabilities over 5 years: stood at $585.2 million in 2022, then fell by 3.73% to $563.4 million in 2023, then increased by 0.77% to $567.7 million in 2024, then rose by 5.19% to $597.2 million in 2025, then retreated by 0.23% to $595.8 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $595.8 million (Q1 2026), $597.2 million (Q4 2025), and $606.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | 595.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 595.79 Mn |
| Dec 31, 2025 | 597.17 Mn |
| Sep 30, 2025 | 606.70 Mn |
| Jun 30, 2025 | 588.39 Mn |
| Mar 31, 2025 | 570.95 Mn |
| Dec 31, 2024 | 567.72 Mn |
| Sep 30, 2024 | 575.89 Mn |
| Jun 30, 2024 | 557.57 Mn |
| Mar 31, 2024 | 570.16 Mn |
| Dec 31, 2023 | 563.38 Mn |
| Sep 30, 2023 | 581.67 Mn |
| Jun 30, 2023 | 573.59 Mn |
| Mar 31, 2023 | 590.01 Mn |
| Dec 31, 2022 | 585.18 Mn |
| Sep 30, 2022 | 596.66 Mn |
| Jun 30, 2022 | 552.63 Mn |
| Mar 31, 2022 | 520.10 Mn |
| Dec 31, 2021 | 410.19 Mn |
| Sep 30, 2021 | 216.22 Mn |
| Sep 30, 2017 | 11.92 Mn |